文献速递免疫规划传染病防控与疫情报告

中国成人黏膜与肌内注射新冠疫苗接种的免疫相关应激及应激相关反应比较

Immunization-related stress and stress-related responses of mucosal versus intramuscular COVID-19 vaccination among adults in China.
PubMed 文献 · Vaccine · 2024-08-01

2023年1月11日至20日在中国开展横断面问卷调查,纳入1073名已接种新冠疫苗的成人,比较黏膜与肌内注射接种者的心理应激水平及免疫应激相关反应(ISRR)。黏膜组应激水平显著低于肌内组(3.39±3.02 vs 3.93±3.24,P=.006),总体ISRR患病率显著更低(38.4% vs 47.9%,P=.002);多因素回归显示黏膜接种与更低应激水平(β=-0.516,95%CI:-0.852至-0.180;P=.003)及更少总体ISRR(OR=0.613,95%CI:0.427至0.881;P=.008)相关,应激在其中起中介作用。

要点

  • 黏膜接种组应激水平3.39±3.02,低于肌内组3.93±3.24(P=.006)。
  • 黏膜组总体ISRR患病率38.4%,低于肌内组47.9%(P=.002)。
  • 多因素回归中黏膜接种与更少总体ISRR相关(OR=0.613,95%CI:0.427至0.881;P=.008)。

核心结论

  • 与肌内注射相比,黏膜新冠疫苗接种与更低心理应激和躯体反应相关,可能有助于提高未来常规或大规模接种的信任与依从性。

研究设计与样本

  • 采用生物心理社会框架设计的横断面问卷调查,于2023年1月11日至20日开展,社区样本共纳入1073名已接种新冠疫苗的成人。
  • 采用多因素回归模型比较两组结局,以bootstrap抽样法检验应激的中介效应,并用倾向性评分匹配进行敏感性分析。

主要发现

  • 单因素分析中,黏膜接种组应激水平3.39±3.02,低于肌内接种组3.93±3.24(P=.006)。
  • 黏膜组总体ISRR患病率38.4%,低于肌内组47.9%(P=.002)。
  • 多因素回归中,黏膜接种与更低应激水平相关(β=-0.516,95%CI:-0.852至-0.180;P=.003),与更少总体ISRR相关(OR=0.613,95%CI:0.427至0.881;P=.008),尤其在神经系统症状方面。
  • 免疫相关应激中介了接种类型与ISRR的关联,对总体ISRR的间接效应估计为0.0663(95%CI:0.0195至0.1346)。

临床怎么用

  • 原文结论指出黏膜新冠疫苗接种与更低心理应激和躯体反应相关,可能有助于提高未来常规或大规模接种的信任与依从性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In late 2022, China became the first country to roll out mucosal COVID-19 vaccines. No prior study has yet compared the immunization stress-related responses (ISRR) among different routes of COVID-19 vaccine delivery. We aimed to compare the immunization-related psychological stress and ISRR between mucosal and intramuscular COVID-19 vaccines. METHODS: A cross-sectional questionnaire survey using a biopsychosocial framework design was performed from January 11 to 20, 2023. Adults with COVID-19 vaccination were eligible for the study, and a total of 1073 adults participated with community-based sample. Primary outcomes were the psychological stress levels and prevalence of ISRR. Multivariate regression models were employed to compare these outcomes between the two vaccination groups. The potential mediating effects of stress on vaccination and ISRR were examined using bootstrap sampling method. To further ensure the robustness of our results, sensitivity analysis with propensity score matching was performed. FINDINGS: In the univariate analysis, participants who received mucosal vaccination reported significantly lower stress levels compared to those who received intramuscular vaccination (3.39 ± 3.02 vs. 3.93 ± 3.24, P = .006). The prevalence of overall ISRR was significantly lower in the mucosal group compared to the intramuscular group (38.4% vs. 47.9%, P = .002). Multivariate regression models revealed that participants who received mucosal vaccination had a significantly lower stress level (β = -0.516, 95% CI: -0.852 to -0.180; P = .003) and 38.7% fewer overall ISRR (OR = 0.613, 95% CI: 0.427 to 0.881; P = .008), particularly in terms of neurological symptoms. The immunization-related stress mediated the association between vaccination type and ISRR, with indirect effects estimated at 0.0663 (95% CI: 0.0195 to 0.1346) for overall ISRR. CONCLUSIONS: Mucosal COVID-19 vaccination was associated with reduced psychological stress and physical responses, as compared to intramuscular vaccination, which may contribute to increased trust and compliance with routine or mass vaccination efforts in the future.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Jiang M, Zhang H, Yao X, et al. Immunization-related stress and stress-related responses of mucosal versus intramuscular COVID-19 vaccination among adults in China. Vaccine. 2024. PMID: 39095276. doi:10.1016/j.vaccine.2024.07.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。